Quanz, M., Hagemann, U. B., Zitzmann-Kolbe, S., Stelte-Ludwig, B., Golfier, S., Elbi, C., . . . Schatz, C. A. (2018). Anetumab ravtansine inhibits tumor growth and shows additive effect in combination with targeted agents and chemotherapy in mesothelin-expressing human ovarian cancer models. Oncotarget.

Quanz, Maria, Urs B. Hagemann, Sabine Zitzmann-Kolbe, Beatrix Stelte-Ludwig, Sven Golfier, Cem Elbi, Dominik Mumberg, Karl Ziegelbauer, ja Christoph A. Schatz. "Anetumab Ravtansine Inhibits Tumor Growth and Shows Additive Effect in Combination With Targeted Agents and Chemotherapy in Mesothelin-expressing Human Ovarian Cancer Models." Oncotarget 2018.

Quanz, Maria, et al. "Anetumab Ravtansine Inhibits Tumor Growth and Shows Additive Effect in Combination With Targeted Agents and Chemotherapy in Mesothelin-expressing Human Ovarian Cancer Models." Oncotarget 2018.